Abstract
Dolutegravir (DTG) has shown effectiveness in combination with rilpivirine in with experience of antiretroviral therapy (ART) and with 3TC in naïve patients (GEMINI trial). The main objectives of this real-life study were to analyze the effectiveness and safety of 3TC plus DTG in virologically suppressed HIV-1 patients and to conduct a pharmacoeconomic analysis.We conducted an observational, retrospective and multicenter study of HIV+ patients pretreated for at least 6 months with ART that was then simplified to 3TC + DTG for any reason. We gathered data on viral loads (VLs) during exposure to the DT, calculating the rate with VL < 50 copies/mL at week 48, and on associated adverse effects.The 177 HIV+ patients were collected, 77.4% male, with average age of 48.5 years and mean count of 252.2cell/μL CD4+ nadir lymphocytes; 96.6% had VL < 50 copies/mL and 674 cells/μL CD4+ lymphocytes. Median time since HIV diagnosis was 15 years, and median ART duration was 13 years, and 34.5% of patients were on mono- or dual-therapy before the switch. At week 48, 82.4% of patients had VL < 50 cop/μL using an intention-to-treat (ITT) analysis, 89.6% according to mITT, and 96.7% according to Per-Protocol analysis. 3.3% patients had virological ...Continue Reading
References
Jun 16, 2010·BMJ : British Medical Journal·Iosief Abraha, Alessandro Montedori
Dec 25, 2013·PloS One·Hasina SamjiUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Apr 12, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Danielle A Osterholzer, Mitchell Goldman
Jun 13, 2015·The Lancet Infectious Diseases·José R ArribasUNKNOWN OLE/RIS-EST13 Study Group
Jun 13, 2015·The Lancet Infectious Diseases·José A Perez-MolinaUNKNOWN GESIDA 7011 Study Group
Nov 6, 2015·The Lancet Infectious Diseases·Anthony MillsUNKNOWN GS-US-292-0109 team
Dec 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael P GirouardRochelle P Walensky
Mar 18, 2017·BMC Infectious Diseases·Franco MaggioloCristina Mussini
Apr 13, 2017·Antiviral Therapy·Benoît TrottierMichael Aboud
Apr 19, 2017·The Journal of Antimicrobial Chemotherapy·Giulia CucchettoErcole Concia
May 26, 2017·Journal of the International AIDS Society·Pedro CahnOmar Sued
Jul 12, 2017·AIDS·Luigia ElziUNKNOWN Swiss HIV Cohort Study Group
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Federico PulidoUNKNOWN DUAL-GESIDA-8014-RIS-EST45 Study Group
Dec 19, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Babafemi O TaiwoRoy M Gulick
Jan 3, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Babafemi O TaiwoPaul E Sax
Jan 10, 2018·Lancet·Josep M LlibreMichael Aboud
Apr 3, 2018·The Journal of Antimicrobial Chemotherapy·Jose L BlancoUNKNOWN DOLAM Study Team
Jun 10, 2018·Enfermedades infecciosas y microbiología clínica·José Antonio Pérez-MolinaJosep M Gatell
Nov 14, 2018·Lancet·Pedro CahnUNKNOWN GEMINI Study Team
Nov 27, 2018·The Journal of Antimicrobial Chemotherapy·Véronique JolyUNKNOWN LAMIDOL Study Group
Jan 19, 2019·BMC Infectious Diseases·Alberto BorghettiSimona Di Giambenedetto
Feb 7, 2019·The Journal of Antimicrobial Chemotherapy·Gianmaria BaldinSimona Di Giambenedetto
Citations
Feb 19, 2020·Expert Review of Anti-infective Therapy·Arturo CicculloSimona Di Giambenedetto
Apr 12, 2020·The Journal of Antimicrobial Chemotherapy·Sanjay PujariVivek Bele
Mar 22, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alberto BorghettiSimona Di Giambenedetto
Jul 31, 2020·The Journal of Antimicrobial Chemotherapy·Leonardo CalzaPierluigi Viale
Jul 25, 2020·Medicine·Takeya TsutsumiHiroshi Yotsuyanagi
Dec 23, 2019·Drugs·Lesley J Scott
Nov 28, 2019·Journal of Clinical Medicine·Manuela ColafigliAlessandra Latini
Dec 8, 2020·AIDS Research and Human Retroviruses·Gianmaria BaldinSimona Di Giambenedetto
Feb 3, 2021·HIV Medicine·Y S PunekarA de Ruiter
May 6, 2021·Diagnostics·Valeria Cento, Carlo Federico Perno
Jul 24, 2021·The Annals of Pharmacotherapy·Inés MendozaMiguel Torralba
Aug 7, 2021·The Lancet. HIV·Jhon RojasUNKNOWN DOLAM study group
Aug 25, 2021·Infectious Diseases and Therapy·Rickesh PatelJustin Koteff
Aug 28, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Arturo CicculloGianmaria Baldin
Oct 16, 2021·The Journal of Antimicrobial Chemotherapy·Colin DeschanvresUNKNOWN Dat’AIDS Study Group